BridgeBio Pharma (BBIO) Stock Chart & Stock Price History $49.08 -1.15 (-2.29%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$49.52 +0.45 (+0.91%) As of 08/22/2025 07:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BridgeBio Pharma Stock Price Performance The BridgeBio Pharma (BBIO) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 93.92%, with a year-to-date return of 78.86%. In the past month, the stock has increased 7.49%, reflecting recent market activity. As of the latest close, BridgeBio Pharma traded at $49.08 with a market cap of $9.38 billion and volume of 1.49 million shares. Five years ago, the stock traded at $28.80, representing a 70.42% increase over that period. At the time, it had a market cap of $3.45 billion and a volume of 307,861 shares. Receive BBIO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BridgeBio Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+0.35%1 Month Performance+7.49%3 Month Performance+47.21%Year-To-Date Performance+78.86%1 Year Performance+93.92%5 Year Performance+70.42% BBIO Stock Chart for Sunday, August, 24, 2025 BBIO Chart by TradingView BridgeBio Pharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/22/2025$50.23$49.08-2.29%$50.73$48.841.49 million shs$9.38 billion08/21/2025$48.88$50.23+2.76%$50.25$48.291.34 million shs$9.60 billion08/20/2025$48.91$48.88-0.06%$49.26$48.221.76 million shs$9.34 billion08/19/2025$49.02$48.91-0.22%$49.60$48.032.37 million shs$9.35 billion08/18/2025$51.32$49.02-4.48%$51.00$49.003.00 million shs$9.37 billion08/15/2025$51.18$51.32+0.27%$51.66$50.602.21 million shs$9.81 billion08/14/2025$50.38$51.18+1.59%$51.86$49.752.03 million shs$9.78 billion08/13/2025$49.09$50.38+2.63%$50.51$49.112.22 million shs$9.63 billion08/12/2025$48.24$49.09+1.76%$49.14$47.372.14 million shs$9.38 billion08/11/2025$46.58$48.24+3.56%$48.30$46.292.34 million shs$9.22 billion Get the Latest News and Ratings for BBIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BridgeBio Pharma and its competitors with MarketBeat's FREE daily newsletter. 08/08/2025$45.95$46.58+1.37%$47.24$45.402.50 million shs$8.90 billion08/07/2025$44.81$45.95+2.54%$46.15$44.102.66 million shs$8.73 billion08/06/2025$49.21$44.81-8.94%$45.85$42.0914.11 million shs$8.51 billion08/05/2025$47.75$49.21+3.06%$49.77$47.015.67 million shs$9.34 billion08/04/2025$47.37$47.75+0.80%$48.20$47.212.49 million shs$9.07 billion08/01/2025$47.27$47.37+0.21%$48.03$46.312.22 million shs$8.99 billion07/31/2025$45.62$47.27+3.62%$48.07$45.562.82 million shs$8.98 billion07/30/2025$46.32$45.62-1.51%$46.77$45.111.68 million shs$8.66 billion07/29/2025$46.23$46.32+0.19%$46.83$45.921.46 million shs$8.80 billion07/28/2025$46.30$46.23-0.15%$47.11$46.092.05 million shs$8.78 billion07/25/2025$45.66$46.30+1.40%$46.41$45.271.51 million shs$8.79 billion07/24/2025$46.19$45.66-1.15%$46.77$45.501.59 million shs$8.67 billion07/23/2025$45.77$46.19+0.92%$47.05$45.362.09 million shs$8.77 billion Related Companies BeOne Medicines Stock Price Chart BioNTech Stock Price Chart Insmed Stock Price Chart Teva Pharmaceutical Industries Stock Price Chart Summit Therapeutics Stock Price Chart Genmab A/S Stock Price Chart Viatris Stock Price Chart Ascendis Pharma A/S Stock Price Chart Dr. Reddy's Laboratories Stock Price Chart QIAGEN Stock Price Chart Receive BBIO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BridgeBio Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BBIO) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersNations are at war over what’s in this boxA resource known as Element 29 is quickly becoming one of the most sought-after materials on the planet. Goldm...Behind the Markets | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.On a quiet Friday afternoon, one trader spotted an overlooked stock. He bought shares. He shut down his ...Timothy Sykes | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BridgeBio Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BridgeBio Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access